Come up with a name for your new list and we'll add to it:
Quark Pharmaceuticals raised a round of funding on , . Investors include
Mitsubishi UFJ Capital.
Fremont, California, July 30, 2008 Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing RNA interference (RNAi)-based therapeutics, today announced that i…